Indegene makes strong debut; lists with 45.95% premium on the BSE
Indegene has debuted at Rs 659.70 on the BSE, up by 207.70 points or 45.95% from its issue price of Rs 452.00.
The scrip is currently trading at Rs 541.45, up by 89.45 points or 19.79% from its issue price. It has touched a high and low of Rs 659.70 and Rs 527.80 respectively. So far 13.54 lakh shares were traded on the counter.
The offering, which was open for subscription between May 6, 2024 and May 8, 2024 was subscribed 70.30 times. The issue price was fixed at Rs 452 per share i.e. at upper end of price band of Rs 430-452 apiece.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
